Form 4: Fulgent Genetics CEO Sells Shares for Tax Obligations

Fulgent Genetics CEO Ming Hsieh disposed of 2,944 shares of common stock at $30.15 per share to cover tax liabilities from RSU vesting.

Summary

• Ming Hsieh, CEO, Director, and 10% owner of Fulgent Genetics, Inc. (FLGT), reported a disposition of common stock.
• On November 26, 2025, 2,944 shares of common stock were disposed of at a price of $30.15 per share.
• This transaction was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units (RSUs) granted on February 26, 2024.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.
• Following this transaction, Mr. Hsieh directly beneficially owns 799,221 shares.
• Indirect beneficial ownership includes 7,895,115 shares via the Dynasty Trust, 220,816 shares via The Ming Hsieh Trust, and 2,000 shares via Uniform Transfer to Minor Accounts.

Sentiment

Score: 5

Explanation: The transaction is a routine tax-related disposition of shares upon RSU vesting, which is a standard compensation practice and does not indicate a change in company fundamentals or management's outlook.

Positives

• The transaction represents the vesting of restricted stock units, indicating a component of executive compensation being realized.

Negatives

• The disposition of shares, while routine for tax purposes, reduces the direct beneficial ownership of the CEO.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Industry Context

This filing details a routine insider transaction related to executive compensation, which is a standard practice across publicly traded companies and does not provide specific insights into broader industry trends.

Related Party Transactions

• Securities held by the Dynasty Trust, where Mr. Hsieh is the grantor and serves on the investment committee with his spouse and Jian Xie.
• Securities held by The Ming Hsieh Trust, where Mr. Hsieh is the trustee and possesses sole voting and dispositive power.
• Shares held in Uniform Transfers to Minor Act accounts, where Mr. Hsieh acts as custodian and possesses sole voting and dispositive power.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine tax-related transaction for executive compensation.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Fulgent Genetics, FLGT, Ming Hsieh, Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, RSU Vesting, CEO, Director, 10% Owner, Beneficial Ownership